Methylenedioxyhydroxyethylamphetamine

Methylenedioxyhydroxyethylamphetamine (also known as MDOH) is a lesser-known psychedelic drug and a substituted amphetamine. MDOH was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 100-160 mg, and the duration is listed as 3-6 hours. MDOH produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDOH.

Chemistry

MDOH, or Methylenedioxyhydroxyethylamphetamine, is a compound of the phenethylamine and amphetamine chemical classes. It is an analog of MDMA where the methylenedioxy group has been replaced by a methylenedioxyhydroxyethyl group.

Pharmacology

The pharmacology of MDOH is not well-studied. However, it is known that it acts as a serotonin releasing agent like its analog, MDMA. It is also likely to act as a norepinephrine and dopamine releasing agent.

Effects

The effects of MDOH are not well-documented. It is known to produce few to no effects, which may be due to its metabolism before it reaches the brain. Some users have reported mild psychedelic effects, but these reports are not consistent.

Toxicity and harm potential

The toxicity and harm potential of MDOH are not well-studied. However, due to its structural similarity to other substituted amphetamines, it is likely to have similar risks. These may include neurotoxicity, cardiotoxicity, and a risk of overdose.

Legal status

The legal status of MDOH varies by country. In the United States, it is not specifically listed as a controlled substance, but it may be considered an analog of MDMA, which would make its sale, possession, or use illegal.

See also

• MDMA
• MDEA
• Methylone
• Substituted amphetamine
• Psychedelic drug